3625 results for «2113»

Filter By

3625 results

Clinical event reductions in high-risk hypertension patients treated with renal denervation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...

Clinical event reductions in high-risk hypertension patients treated with renal denervation

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

Stent failure - LIVE Case

11 Oct 2025 – From AICT-AsiaPCR 2025

This educational session presents a live case from Apollo Hospitals, Chennai, focusing on stent failure management. It emphasizes the critical role of imaging in optimizing treatment for in-stent restenosis, discusses essential lesion preparation tools, and reviews various therapeutic options to improve patient care.

 LIVE Educational Case from...

Stent failure - LIVE Case

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

Future directions of drug-coated balloon angioplasty

06 Feb 2025

Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.

Dr. F. Alfonso

Author

Fernando Alfonso
Javier Cuesta

Author

Javier Cuesta
Future directions of drug-coated balloon angioplasty
Didn’t find what you were looking for?